Social outcomes in young adult survivors of low incidence childhood cancers
- First Online:
- 245 Downloads
The intensity and duration of childhood cancer treatment may disrupt psychosocial development and thereby cause difficulties in transition into adulthood. The study objective was to assess social outcomes in early adulthood after successful treatment for childhood acute myeloid leukemia (AML), Wilms tumor (WT) and infratentorial astrocytoma (IA).
Nordic patients treated for AML, WT and IA from 1985 to 2001 identified from a database administered by NOPHO (Nordic Society of Paediatric Haematology and Oncology) were invited to participate in a postal survey. All cancer-free survivors treated at age >1 year who were >19 years at time of study were eligible. Seventy-four percent; 247/335 responded. An age-equivalent group (N = 1,814) from a Norwegian Census Study served as controls.
Mean age of survivors was 23 years (range 19–34), 55% females. The proportion with academic education (≥4 years) was similar in survivors and controls (28 vs. 32%). Fifty-nine percent of survivors were employed compared to 77% among controls (p < .01). More survivors were recipients of social benefits (6.7 vs. 3.1%, p < .01). There were no differences in marital status but parenthood was more common among controls (37 vs. 27%, p = .01). Controls lived longer in their parental homes (p = .01). Cancer type or treatment intensity had no statistically significant impact on results, except for parenthood.
Conclusions and Implications for Cancer Survivors
The study revealed important differences in social outcomes between survivors and controls early in adult life. Specific difficulties pertain to studying social status in early adulthood because of the natural transition characteristics for this age group. Therefore, longer follow-up is warranted.
KeywordsChildhood cancer survivors Education Employment Living situation
- 2.Hewitt M, Simone J. Childhood cancer survivorship; improving care and quality of life. Washington DC: National Academies; 2003.Google Scholar
- 21.Gustafsson G, Lie S. Acute leukemias. In: Voute PA, Kalifa C, Barrett A, editors. Cancer in children—clinical management. Oxford: Oxford University Press; 1998. p. 99–118.Google Scholar
- 22.Medlock M. Infratentorial astrocytoma. In: Keating R, Goodrich J, Packer R, editors. Tumors of the pediatric central nervous system. New York: Thieme; 2001. p. 199–205.Google Scholar
- 23.de Camargo B, Weitzman S. Nephroblastoma. In: Voute PA, Kalifa C, Barrett A, editors. Cancer in children—clinical management. Oxford: Oxford University Press; 1998. p. 259–73.Google Scholar
- 37.Schmiegelow K. Leukemias and lymphomas. In: NOPHO educational book—an introduction to Paediatric Oncology. Unpublished; 2007.Google Scholar
- 38.Nordic Society for Paediatric Haematology and Oncology. Annual Report. 2002.Google Scholar
- 39.HUNT. Available from http://www.hunt.ntnu.no/ (16.08.06).
- 40.Ware J, Gandek B, Keller S, IQOLA Group. Evaluating instruments used cross-nationally: methods from the IQOLA project. In: Spilker B, editor. Quality of life and pharmaeconomics in clinical trials. Philadelphia: Lippincott-Raven; 1996. p. 681–92.Google Scholar
- 41.Levekår 2002. Available from http://www.nsd.uib.no/data/ny_individ/norStudy/norStudy.cfm?norStudyID=662 (03.03.07).